Spitalul Clinic de Urgenta Bagdasar-Arseni

The Cardiology department at Spitalul Clinic de Urgenta Bagdasar-Arseni is investigating new strategies to lower the risk of serious heart and vascular events in patients with atherosclerotic cardiovascular disease and those receiving Factor Xa inhibitors who need urgent surgery.

• Reducing major adverse cardiovascular events (MACE-PLUS)
• Managing haemostasis during urgent invasive procedures
• Evaluating novel oral anticoagulant reversal agents

These studies aim to improve patient safety and outcomes by testing innovative therapies that address both clot prevention and bleeding risk.

Research at the site focuses on chronic venous conditions, particularly venous leg ulcers, seeking better methods for wound cleaning and preparation.

• Advanced debridement technologies for ulcer care
• Safety and efficacy of topical agents in wound healing
• Optimizing recovery timelines for chronic ulcer patients

The goal is to accelerate healing, reduce infection risk, and enhance quality of life for individuals suffering from persistent leg ulcers.

The clinic’s trials also address disorders of the skin and connective tissue, with a spotlight on the use of the EscharEx formulation to improve wound bed preparation in ulcer management.

• Efficacy of eschar removal in chronic wounds
• Patient‑reported outcomes and comfort during treatment
• Integration of new wound‑care protocols into standard practice

By evaluating this novel topical therapy, researchers hope to set new standards for treating difficult‑to‑heal skin lesions.